Cargando…

Development and validation of a risk prediction score for severe acute pancreatitis

INTRODUCTION: The available prognostic scoring systems for severe acute pancreatitis (SAP) have limitations that restrict their clinical value. The aim of this study was to develop a simple model (score) that could rapidly identify those at risk for SAP. METHODS: We derived a risk model using a retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Wandong, Lillemoe, Keith D., Pan, Shuang, Zimmer, Vincent, Kontopantelis, Evangelos, Stock, Simon, Zippi, Maddalena, Wang, Chao, Zhou, Mengtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505180/
https://www.ncbi.nlm.nih.gov/pubmed/31068202
http://dx.doi.org/10.1186/s12967-019-1903-6
_version_ 1783416708402249728
author Hong, Wandong
Lillemoe, Keith D.
Pan, Shuang
Zimmer, Vincent
Kontopantelis, Evangelos
Stock, Simon
Zippi, Maddalena
Wang, Chao
Zhou, Mengtao
author_facet Hong, Wandong
Lillemoe, Keith D.
Pan, Shuang
Zimmer, Vincent
Kontopantelis, Evangelos
Stock, Simon
Zippi, Maddalena
Wang, Chao
Zhou, Mengtao
author_sort Hong, Wandong
collection PubMed
description INTRODUCTION: The available prognostic scoring systems for severe acute pancreatitis (SAP) have limitations that restrict their clinical value. The aim of this study was to develop a simple model (score) that could rapidly identify those at risk for SAP. METHODS: We derived a risk model using a retrospective cohort of 700 patients by logistic regression and bootstrapping methods. The discriminative power of the risk model was assessed by calculating the area under the receiver operating characteristic curves (AUC). The classification and regression tree (CART) analysis was used to create risk categories. The model was internally validated by a tenfold cross-validation and externally validated in a separate prospective cohort of 194 patients. RESULTS: The incidence of SAP was 9.7% in the derivation cohort and 9.3% in the validation cohort. A prognostic score (We denoted it as the SABP score), ranging from 0 to 10, consisting of systemic inflammatory response syndrome, serum albumin, blood urea nitrogen and pleural effusion, was developed by logistic regression and bootstrapping analysis. Patients could be divided into three risk categories according to total SABP score based on CART analysis. The mean probability of developing SAP was 1.9%, 12.8% and 41.6% in patients with low (0–3), moderate (4–6) and high (7–10) SABP score, respectively. The AUCs of prognostic score in tenfold cross-validation was 0.873 and 0.872 in the external validation. CONCLUSION: Our risk prediction score may assist physicians in predicting the development of SAP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1903-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6505180
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65051802019-05-10 Development and validation of a risk prediction score for severe acute pancreatitis Hong, Wandong Lillemoe, Keith D. Pan, Shuang Zimmer, Vincent Kontopantelis, Evangelos Stock, Simon Zippi, Maddalena Wang, Chao Zhou, Mengtao J Transl Med Research INTRODUCTION: The available prognostic scoring systems for severe acute pancreatitis (SAP) have limitations that restrict their clinical value. The aim of this study was to develop a simple model (score) that could rapidly identify those at risk for SAP. METHODS: We derived a risk model using a retrospective cohort of 700 patients by logistic regression and bootstrapping methods. The discriminative power of the risk model was assessed by calculating the area under the receiver operating characteristic curves (AUC). The classification and regression tree (CART) analysis was used to create risk categories. The model was internally validated by a tenfold cross-validation and externally validated in a separate prospective cohort of 194 patients. RESULTS: The incidence of SAP was 9.7% in the derivation cohort and 9.3% in the validation cohort. A prognostic score (We denoted it as the SABP score), ranging from 0 to 10, consisting of systemic inflammatory response syndrome, serum albumin, blood urea nitrogen and pleural effusion, was developed by logistic regression and bootstrapping analysis. Patients could be divided into three risk categories according to total SABP score based on CART analysis. The mean probability of developing SAP was 1.9%, 12.8% and 41.6% in patients with low (0–3), moderate (4–6) and high (7–10) SABP score, respectively. The AUCs of prognostic score in tenfold cross-validation was 0.873 and 0.872 in the external validation. CONCLUSION: Our risk prediction score may assist physicians in predicting the development of SAP. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12967-019-1903-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-08 /pmc/articles/PMC6505180/ /pubmed/31068202 http://dx.doi.org/10.1186/s12967-019-1903-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hong, Wandong
Lillemoe, Keith D.
Pan, Shuang
Zimmer, Vincent
Kontopantelis, Evangelos
Stock, Simon
Zippi, Maddalena
Wang, Chao
Zhou, Mengtao
Development and validation of a risk prediction score for severe acute pancreatitis
title Development and validation of a risk prediction score for severe acute pancreatitis
title_full Development and validation of a risk prediction score for severe acute pancreatitis
title_fullStr Development and validation of a risk prediction score for severe acute pancreatitis
title_full_unstemmed Development and validation of a risk prediction score for severe acute pancreatitis
title_short Development and validation of a risk prediction score for severe acute pancreatitis
title_sort development and validation of a risk prediction score for severe acute pancreatitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505180/
https://www.ncbi.nlm.nih.gov/pubmed/31068202
http://dx.doi.org/10.1186/s12967-019-1903-6
work_keys_str_mv AT hongwandong developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT lillemoekeithd developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT panshuang developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT zimmervincent developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT kontopantelisevangelos developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT stocksimon developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT zippimaddalena developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT wangchao developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis
AT zhoumengtao developmentandvalidationofariskpredictionscoreforsevereacutepancreatitis